valine has been researched along with Brain Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K | 1 |
| Amarenco, P; Cambien, F; Canaple, S; Chédru, F; Elbaz, A; Poirier, O | 1 |
2 other study(ies) available for valine and Brain Infarction
| Article | Year |
|---|---|
Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice.
Topics: Animals; Antihypertensive Agents; Bone Marrow Transplantation; Brain Infarction; Brain Ischemia; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reperfusion Injury; Stromal Cells; Survival Rate; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2008 |
The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Brain Infarction; Cholesterol; Factor XIII; Female; Homozygote; Humans; Leucine; Macromolecular Substances; Male; Middle Aged; Polymorphism, Genetic; Reference Values; Risk Factors; Smoking; Valine | 2000 |